By product, the global Transcatheter Heart Valve Replacement market size can be segmented into transcatheter pulmonary valve replacement, transcatheter mitral valve repair & replacement, and transcatheter aortic valve replacement.
Transcatheter aortic valve replacement (TAVR) is a minimally invasive method to replace a damaged and old valve. TAVR is also known as transcatheter aortic valve implantation (TAVI). Transcatheter aortic valve replacement (TAVR) is the procedure for people who have a high or immediate risk of complications from open-heart surgery. It aids patients to get relief from aortic valve stenosis. Aortic valve stenosis happens when the aortic valve of the heart calcifies and thickens. It protects the valve from opening to its full width and limits the flow of blood from the heart to the rest of the body. The aortic valve stenosis causes fainting, chest pain, leg pain, fatigue, and shortness of breath. It can also result in a sudden cardiac attack and heart failure.
Report Scope:
Report Attribute | Details |
---|---|
Base Year | 2022 |
Historic Years | 2018 - 2022 |
Forecast Years | 2023 - 2030 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2023 to 2030 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
The increasing number of patients suffering from several cardiovascular diseases like coronary artery diseases, heart failure, hypertension, and many others is one of the major reasons driving the growth of the global transcatheter heart valve replacement market. Cardiovascular diseases cause improper functioning of aortic valves. Hence it boosts the demand for efficient procedures for valve replacements. The growing investments in the healthcare sector to strengthen the medical system are boosting the growth of the global transcatheter heart valve replacement market. The technological advancements and developments in the transcatheter aortic valve replacement procedure are anticipated to bolster the market growth globally.
Furthermore, the growing adoption of minimal invasive surgery to reduce the time duration of hospital stay and healthcare expenditure is projected to fuel the growth of the global market. The constantly growing geriatric population coupled with the increasing incidences of heart valve diseases is fostering the market to grow significantly during the forecast period. The manufacturers of advanced devices are emphasizing extensive research and development activities to develop more modern and minimal invasive methods to treat the patients is positively shaping the trajectory of the global transcatheter heart valve replacement market during the forecast period.
The global transcatheter heart valve replacement market can be segmented into application, surgical approach, product, end-use, and region.
By application, the market can be segmented into pulmonary valvular heart disease, mitral valvular heart disease, and aortic valvular heart disease.
By surgical approach, the market can be segmented into the transapical approach, transfemoral approach, and others. The transapical approach segment holds hegemony over others due to the provision of convenient wiring with outstanding controllability and antegrade approach. It aids in quick accessibility to the aortic valve easily and hence the approach is used on large scale in transcatheter aortic valve implementation. Moreover, the approach maintains close proximity to identify, target, and control implantation.
By product, the market can be segmented into transcatheter pulmonary valve replacement, transcatheter mitral valve repair & replacement, and transcatheter aortic valve replacement. The transcatheter mitral valve repair & replacement segment dominates the market over others.
By end-use, the market can be segmented into cath labs and hospitals. The hospital segment accounts for the largest share in the global transcatheter heart valve replacement market owing to the reimbursement done by the hospital. Furthermore, the presence of a professional surgeon in the hospital and advanced tools utilized in the procedure is projecting the growth of the segment.
North America holds the largest share in the global transcatheter heart valve replacement market due to the growing incidences of heart valve disorders in the region. The favorable reimbursement procedures by the medicare centers are also fueling the growth of the regional market growth.
Europe is anticipated to witness huge growth during the forecast period owing to the growing technological advancements and surging incidences of cardiovascular diseases.
Some of the significant players in the global transcatheter heart valve replacement market are Braile Biomedica, Edwards Lifesciences Corporation, Cook Medical Inc., JC Medical, Inc., Venus Medtech, Inc., Medtronic, plc, NVT AG, Boston Scientific Corporation, JenaValve Technology, Inc., Abbott Laboratories Inc., Bracco S.p.A. (HLT, Inc.), Meril Life Sciences Pvt. Ltd., and St. Jude Medical, Inc.
By product
By surgical approach
By end-use
What Reports Provides
FrequentlyAsked Questions
The increasing number of patients suffering from several cardiovascular diseases like coronary artery diseases, heart failure, hypertension, and many others is one of the major reasons driving the growth of the global transcatheter heart valve replacement market. Cardiovascular diseases cause improper functioning of aortic valves. Hence it boosts the demand for efficient procedures for valve replacements.
Some of the significant players in the global transcatheter heart valve replacement market are Braile Biomedica, Edwards Lifesciences Corporation, Cook Medical Inc., JC Medical, Inc., Venus Medtech, Inc., Medtronic, plc, NVT AG, Boston Scientific Corporation, JenaValve Technology, Inc., Abbott Laboratories Inc., Bracco S.p.A. (HLT, Inc.), Meril Life Sciences Pvt. Ltd., and St. Jude Medical, Inc.
North America holds the largest share in the global transcatheter heart valve replacement market due to the growing incidences of heart valve disorders in the region. The favorable reimbursement procedures by the medicare centers are also fueling the growth of the regional market growth.
The global transcatheter heart valve replacement market can be segmented into application, surgical approach, product, end-use, and region.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed